{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:09:39Z","timestamp":1790064579943,"version":"4.0.1"},"reference-count":65,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T00:00:00Z","timestamp":1520640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Antimicrobial peptides (AMPs) hold promise as the next generation of antimicrobial agents, but often suffer from rapid degradation in vivo. Modifying AMPs with non-proteinogenic residues such as peptoids (oligomers of N-alkylglycines) provides the potential to improve stability. We have identified two novel peptoid-based compounds, B1 and D2, which are effective against the canine skin pathogen Staphylococcus pseudintermedius, the main cause of antibiotic use in companion animals. We report on their potential to treat infections topically by characterizing their release from formulation and in vitro ADME properties. In vitro ADME assays included skin penetration profiles, stability to proteases and liver microsomes, and plasma protein binding. Both B1 and D2 were resistant to proteases and &gt;98% bound to plasma proteins. While half-lives in liver microsomes for both were &gt;2 h, peptoid D2 showed higher stability to plasma proteases than the peptide-peptoid hybrid B1 (&gt;2 versus 0.5 h). Both compounds were suitable for administration in an oil-in-water cream formulation (50% release in 8 h), and displayed no skin permeation, in the absence or presence of skin permeability modifiers. Our results indicate that these peptoid-based drugs may be suitable as antimicrobials for local treatment of canine superficial pyoderma and that they can overcome the inherent limitations of stability encountered in peptides.<\/jats:p>","DOI":"10.3390\/molecules23030630","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T13:13:48Z","timestamp":1520860428000},"page":"630","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["In Vitro ADME Properties of Two Novel Antimicrobial Peptoid-Based Compounds as Potential Agents against Canine Pyoderma"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2348-3688","authenticated-orcid":false,"given":"Ines","family":"Greco","sequence":"first","affiliation":[{"name":"Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen \u00d8, Denmark"},{"name":"Department of Food Science, University of Copenhagen, Rolighedsvej 30, DK-1958 Frederiksberg, Denmark"},{"name":"Zoetis Inc., 333 Portage St., Kalamazoo, MI 49007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Hummel","sequence":"additional","affiliation":[{"name":"Zoetis Inc., 333 Portage St., Kalamazoo, MI 49007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaspreet","family":"Vasir","sequence":"additional","affiliation":[{"name":"Zoetis Inc., 333 Portage St., Kalamazoo, MI 49007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Watts","sequence":"additional","affiliation":[{"name":"Zoetis Inc., 333 Portage St., Kalamazoo, MI 49007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Koch","sequence":"additional","affiliation":[{"name":"Zoetis Inc., 333 Portage St., Kalamazoo, MI 49007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen \u00d8, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen \u00d8, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9932-5996","authenticated-orcid":false,"given":"Peter","family":"Damborg","sequence":"additional","affiliation":[{"name":"Department of Veterinary and Animal Sciences, University of Copenhagen, Stigb\u00f8jlen 4, 1870 Frederiksberg C, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9357-8001","authenticated-orcid":false,"given":"Paul","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen \u00d8, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,3,10]]},"reference":[{"key":"ref_1","unstructured":"WHO (2014). Antimicrobial Resistance, WHO. Global Report on Surveillance."},{"key":"ref_2","unstructured":"European Centre for Disease, Prevention and Control (2015). Antimicrobial Resistance in Europe in 2014, ECDC. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/vr.155.9.259","article-title":"Survey of condition-based prescribing of antimicrobial drugs for dogs at a veterinary teaching hospital","volume":"155","author":"Rantala","year":"2004","journal-title":"Vet. Rec."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5326\/0380407","article-title":"Frequency of Isolation and Antimicrobial Susceptibility Patterns of Staphylococcus intermedius and Pseudomonas aeruginosa Isolates From Canine Skin and Ear Samples Over a 6-Year Period (1992\u20131997)","volume":"38","author":"Petersen","year":"2002","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/jac\/dkq078","article-title":"Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: An international multicentre study","volume":"65","author":"Perreten","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/vde.12118","article-title":"Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases)","volume":"25","author":"Hillier","year":"2014","journal-title":"Vet. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Molchanova, N., Hansen, P.R., and Franzyk, H. (2017). Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs. Molecules, 22.","DOI":"10.3390\/molecules22091430"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: Current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4155\/fmc.12.213","article-title":"Peptides as the next generation of anti-infectives","volume":"5","author":"Mercer","year":"2013","journal-title":"Futur. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/07388551.2011.594423","article-title":"Antimicrobial peptides: Key components of the innate immune system","volume":"32","author":"Pasupuleti","year":"2012","journal-title":"Crit. Rev. Biotechnol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Hansen, P.R. (2017). Antimicrobial Peptides: An Introduction. Antimicrobial Peptides: Methods and Protocols, Springer.","DOI":"10.1007\/978-1-4939-6737-7"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3390\/ph6081055","article-title":"Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics","volume":"6","author":"Aoki","year":"2013","journal-title":"Pharmaceuticals"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/ph8010123","article-title":"Antimicrobial Peptides in 2014","volume":"8","author":"Wang","year":"2015","journal-title":"Pharmaceuticals"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1208\/s12248-014-9687-3","article-title":"Strategic Approaches to Optimizing Peptide ADME Properties","volume":"17","author":"Di","year":"2015","journal-title":"AAPS J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1128\/AAC.00578-11","article-title":"Functional Synergy between Antimicrobial Peptoids and Peptides against Gram-Negative Bacteria","volume":"55","author":"Chongsiriwatana","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_17","first-page":"299","article-title":"Peptoids as potential therapeutics","volume":"11","author":"Zuckermann","year":"2009","journal-title":"Curr. Opin. Mol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1039\/b817980h","article-title":"Structure\u2013function relationships in peptoids: Recent advances toward deciphering the structural requirements for biological function","volume":"7","author":"Fowler","year":"2009","journal-title":"Org. Biomol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/03009734.2014.901445","article-title":"Antibiotic resistance-consequences for animal health, welfare, and food production","volume":"119","author":"Bengtsson","year":"2014","journal-title":"Upsala J. Med. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cvsm.2014.11.005","article-title":"Antimicrobial Stewardship in Small Animal Veterinary Practice: From Theory to Practice","volume":"45","author":"Guardabassi","year":"2015","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/ilar.51.3.193","article-title":"One Health Perspective","volume":"51","author":"Monath","year":"2010","journal-title":"ILAR J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1007\/s00018-008-8188-x","article-title":"Antimicrobial peptides: Natural templates for synthetic membrane-active compounds","volume":"65","author":"Giuliani","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"12316","DOI":"10.1074\/jbc.M413406200","article-title":"Rational Design of \u03b1-Helical Antimicrobial Peptides with Enhanced Activities and Specificity\/Therapeutic Index","volume":"280","author":"Chen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1128\/AAC.50.4.1480-1488.2006","article-title":"Adding selectivity to antimicrobial peptides: Rational design of a multidomain peptide against Pseudomonas spp.","volume":"50","author":"Eckert","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1473-3099(15)00466-1","article-title":"Alternatives to antibiotics-a pipeline portfolio review","volume":"16","author":"Czaplewski","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/anie.199305431","article-title":"Peptoids\u2014A new approach to the development of pharmaceuticals","volume":"32","author":"Kessler","year":"1993","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.2174\/138161211797416066","article-title":"Peptoids: Bio-Inspired Polymers as Potential Pharmaceuticals","volume":"17","author":"Dohm","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0708254105","article-title":"Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides","volume":"105","author":"Chongsiriwatana","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s00726-012-1275-1","article-title":"beta-Peptoids: Synthesis of a novel dimer having a fully extended conformation","volume":"43","author":"Martelli","year":"2012","journal-title":"Amino Acids"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1128\/AAC.00237-15","article-title":"Structure-Activity Relationship Study of Novel Peptoids That Mimic the Structure of Antimicrobial Peptides","volume":"59","author":"Mojsoska","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000119707","article-title":"Antimicrobial activities of twenty lysine-peptoid hybrids against clinically relevant bacteria and fungi","volume":"54","author":"Ryge","year":"2008","journal-title":"Chemotherapy"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1016\/j.bmc.2006.02.034","article-title":"Potent antibacterial lysine-peptoid hybrids identified from a positional scanning combinatorial library","volume":"14","author":"Ryge","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1747-0285.2010.01067.x","article-title":"Antimicrobial beta-Peptides and alpha-Peptoids","volume":"77","author":"Godballe","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/cmdc.201600553","article-title":"Lysine-Based \u03b1-peptide\/\u03b2-peptoid peptidomimetics: Influence of hydrophobicity, fluorination and distribution of cationic charge on antimicrobial activity and cytotoxicity","volume":"20","author":"Molchanova","year":"2017","journal-title":"ChemMedChem"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijantimicag.2012.09.014","article-title":"High in vitro antimicrobial activity of beta-peptoid-peptide hybrid oligomers against planktonic and biofilm cultures of Staphylococcus epidermidis","volume":"41","author":"Liu","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1039\/C6MD00648E","article-title":"Exploring the links between peptoid antibacterial activity and toxicity","volume":"8","author":"Bolt","year":"2017","journal-title":"MedChemComm"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1021\/bc300091d","article-title":"In vivo Biodistribution and Small Animal PET of Cu-64-Labeled Antimicrobial Peptoids","volume":"23","author":"Seo","year":"2012","journal-title":"Bioconjugate Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2008.04.097","article-title":"Intranasal administration delivers peptoids to the rat central nervous system","volume":"439","author":"Ross","year":"2008","journal-title":"Neurosci. Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"12936","DOI":"10.1021\/ja075469+","article-title":"Periodate-triggered cross-linking reveals Sug2\/Rpt4 as the molecular target of a peptoid inhibitor of the 19S proteasome regulatory particle","volume":"129","author":"Lim","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"ref_40","first-page":"65","article-title":"Peptoid-based PET imaging of vascular endothelial growth factor receptor (VEGFR) expression","volume":"1","author":"Hao","year":"2011","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1099-081X(199903)20:2<69::AID-BDD153>3.0.CO;2-B","article-title":"Absorption and disposition of a tripeptoid and a tetrapeptide in the rat","volume":"20","author":"Wang","year":"1999","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-3164.1999.00185.x","article-title":"Mupirocin, fusidic acid and bacitracin: Activity, action and clinical uses of three topical antibiotics","volume":"10","author":"Werner","year":"1999","journal-title":"Vet. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1586\/14787210.5.5.773","article-title":"Topical triple-anti biotic ointment as a novel therapeutic choice in wound management and infection prevention: A practical perspective","volume":"5","author":"Bonomo","year":"2007","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1086\/593185","article-title":"Topical versus Systemic Antimicrobial Therapy for Treating Mildly Infected Diabetic Foot Ulcers: A Randomized, Controlled, Double-Blinded, Multicenter Trial of Pexiganan Cream","volume":"47","author":"Lipsky","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5173(99)00307-5","article-title":"Controlled release of vancomycin from Poloxamer 407 gels","volume":"192","author":"Veyries","year":"1999","journal-title":"Int. J. Pharm."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Czyzewski, A.M., Jenssen, H., Fjell, C.D., Waldbrook, M., Chongsiriwatana, N.P., Yuen, E., Hancock, R.E.W., and Barron, A.E. (2016). In vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0135961"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","article-title":"The 500 Dalton rule for the skin penetration of chemical compounds and drugs","volume":"9","author":"Bos","year":"2000","journal-title":"Exp. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wise, D. (2000). Handbook of Pharmaceutical Controlled Release Technology, CRC Press.","DOI":"10.1201\/9781482289985"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejps.2013.09.009","article-title":"Influence of skin penetration enhancers on skin barrier function and skin protease activity","volume":"51","author":"Mohammed","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2013.02.040","article-title":"Skin penetration enhancers","volume":"447","author":"Lane","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2004.02.028","article-title":"Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A","volume":"97","author":"Verma","year":"2004","journal-title":"J. Controll. Release"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1208\/s12249-008-9107-z","article-title":"Control of Transdermal Permeation of Hydrocortisone Acetate from Hydrophilic and Lipophilic Formulations","volume":"9","author":"Fini","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"18040","DOI":"10.3390\/ijms151018040","article-title":"Novel Formulations for Antimicrobial Peptides","volume":"15","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/S0960-894X(01)80691-0","article-title":"Proteolytic studies of homologous peptide and N-substituted glycine","volume":"4","author":"Miller","year":"1994","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1124\/dmd.105.004259","article-title":"A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes","volume":"33","author":"Riley","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/03602530701690366","article-title":"Drug-metabolizing enzymes in the skin of man, rat, and pig","volume":"39","author":"Oesch","year":"2007","journal-title":"Drug Metab. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"9367","DOI":"10.1073\/pnas.89.20.9367","article-title":"Peptoids: A modular approach to drug discovery","volume":"89","author":"Simon","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Krishna, R., and Yu, L. (2008). Introduction to Biopharmaceutics and its Role in Drug Development. Biopharmaceutics Applications in Drug Development, Springer.","DOI":"10.1007\/978-0-387-72379-2"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12248-008-9072-1","article-title":"Protein Binding of Antimicrobials: Methods for Quantification and for Investigation of its Impact on Bacterial Killing","volume":"11","author":"Beer","year":"2009","journal-title":"AAPS J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jac\/dkq400","article-title":"Plasma protein binding may reduce antimicrobial activity by preventing intra-bacterial uptake of antibiotics, for example clindamycin","volume":"66","author":"Burian","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"33115","DOI":"10.1074\/jbc.273.50.33115","article-title":"Apolipoprotein A-I binds and inhibits the human antibacterial\/cytotolic peptide LL-37","volume":"273","author":"Wang","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_62","unstructured":"CLSI (2013). Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard\u2014Fourth Edition, CLSI. VET01-A4."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ejmech.2015.08.028","article-title":"The effect of glycine replacement with flexible omega-amino acids on the antimicrobial and haemolytic activity of an amphipathic cyclic heptapeptide","volume":"102","author":"Oddo","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_64","unstructured":"Danish Health and Medicines Authority (2013). 2, Appendix 3, Quality of Medicinal Products, Addition to drug form standards. Danish Medicinal Standards, Danish Health and Medicines Authority."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","article-title":"A Review of Poloxamer 407 Pharmaceutical and Pharmacological Characteristics","volume":"23","author":"Dumortier","year":"2006","journal-title":"Pharm. Res."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/23\/3\/630\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:56:34Z","timestamp":1760194594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/23\/3\/630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,10]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3]]}},"alternative-id":["molecules23030630"],"URL":"https:\/\/doi.org\/10.3390\/molecules23030630","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,10]]}}}